All PlansAdministrativeMedium impact
Newsletter Vol. 13, No. 72
New Jersey Medicaid·NJ·Provider Notice
We identified it
Jun 20, 2026
Summary
New remittance advice statements are being implemented specifically for pharmaceutical providers. This change affects how payment and denial information will be communicated to providers who dispense or bill for pharmaceutical products.
Action Required
Pharmaceutical providers should review the new remittance advice format and train billing staff on interpreting the updated statements. Update any automated payment posting processes to accommodate new remittance advice layouts.